Novelion Therapeutics Inc, (NVLN) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free NVLN Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVoyager Therapeutics, Inc. (VYGR)finance.yahoo.com - April 21 at 7:07 AMVivos Therapeutics Inc (VVOS)investing.com - April 18 at 12:32 AMCentury Therapeutics Inc IPSCmorningstar.com - March 24 at 4:04 AMCymaBay Therapeutics Inc.wsj.com - February 14 at 2:14 AMAclaris Therapeutics Inc (ACRS)investing.com - February 6 at 9:20 PMHighTide Therapeutics Inc (2511)investing.com - January 3 at 12:15 PMIntensity Therapeutics Inc (INTS)investing.com - December 30 at 1:26 AMLeap Therapeutics Inc LPTXmorningstar.com - December 17 at 8:05 AMAileron Therapeutics Inc ALRNmorningstar.com - November 14 at 9:04 AMAtossa Therapeutics Inc ATOSmorningstar.com - November 11 at 9:30 AMBeam Therapeutics Inc BEAMmorningstar.com - November 1 at 5:57 PMAprea Therapeutics Inc APREmorningstar.com - November 1 at 12:57 PMCelldex Therapeutics Inc CLDXmorningstar.com - November 1 at 7:56 AMCARISMA Therapeutics Inc CARMmorningstar.com - October 31 at 3:26 PMIs Viking Therapeutics, Inc. a Buy?finance.yahoo.com - September 29 at 10:14 AMIMUN Immune Therapeutics, Inc.seekingalpha.com - August 26 at 9:29 PMELVN Enliven Therapeutics, Inc.seekingalpha.com - August 24 at 3:37 PMSigilon Therapeutics Inc Ordinary Sharesmorningstar.com - May 10 at 2:21 AMSarepta Therapeutics, Inc. (SRPT)finance.yahoo.com - April 25 at 7:43 PMNurix Therapeutics Inc Ordinary Sharesmorningstar.com - April 20 at 1:17 PMZVSA ZyVersa Therapeutics, Inc.seekingalpha.com - April 20 at 1:17 PMDefence Therapeutics Inc.: Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Millionfinanznachrichten.de - March 26 at 12:01 AMWindtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summarybenzinga.com - February 26 at 1:33 AMFDMT 4D Molecular Therapeutics, Inc.seekingalpha.com - January 28 at 2:22 AMAVTE Aerovate Therapeutics, Inc.seekingalpha.com - January 27 at 9:21 PMRUBY Rubius Therapeutics, Inc.seekingalpha.com - January 24 at 6:03 PMCOEP Coeptis Therapeutics Holdings, Inc.seekingalpha.com - January 24 at 8:02 AMFATE ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Fate Stockholders and Encourages Investors to Contact the Firmbusinesswire.com - January 14 at 12:55 AMAlaunos Therapeutics, Inc. (NASDAQ: TCRT)fool.com - September 29 at 2:25 AM Get Novelion Therapeutics Inc, News Delivered to You Automatically Sign up to receive the latest news and ratings for NVLN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide NVLN Media Mentions By Week NVLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVLN News Sentiment▼0.000.73▲Average Manufacturing News Sentiment NVLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVLN Articles This Week▼00▲NVLN Articles Average Week Get Novelion Therapeutics Inc, News Delivered to You Automatically Sign up to receive the latest news and ratings for NVLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:NVLN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersObama’s Forever Term [exposed]Porter & Company348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novelion Therapeutics Inc, Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
